Artiva Biotherapeutics, Inc. (ARTV)

Artiva Biotherapeutics Revenue

Artiva Biotherapeutics had revenue of $2.60M in the twelve months ending September 30, 2024, down -43.11% year-over-year. In the year 2023, Artiva Biotherapeutics had annual revenue of $33.49M with 579.21% growth.

• Revenue (ttm): $2.60M
• Revenue Growth: -43.11%
• P/S Ratio: 22.61
• Revenue / Employee: $60,488
• Employees: 43
• Market Cap: 266.21M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	33.49M	28.56M	579.21%
Dec 31, 2022	4.93M	2.93M	146.30%
Dec 31, 2021	2.00M	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.